Short-Term Outcomes and Stoma-Related Morbidity of Diverting Ileostomy After Laparoscopic Total Mesorectal Excision Following Neoadjuvant Chemoradiotherapy for Mid- and Distal Rectal Cancer: A Retrospective Single-Center Study
Findings support careful patient selection when balancing the potential benefits of fecal diversion against stoma-related morbidity in DI after laparoscopic total mesorectal excision following neoadjuvant chemoradiotherapy for mid- and distal rectal cancer.
Abstract
Background and Objectives: Diverting ileostomy (DI) is frequently used after low rectal cancer surgery to mitigate the clinical consequences of anastomotic leakage (AL). However, its potential benefits must be balanced against stoma-related morbidity. This study aimed to evaluate short-term postoperative outcomes and stoma-related morbidity associated with DI after laparoscopic total mesorectal excision (TME) following neoadjuvant chemoradiotherapy (nCRT) for mid- and distal rectal cancer. Methods: This retrospective single-center cohort study included 104 of 233 patients assessed for eligibility who had locally advanced mid- or distal rectal adenocarcinoma and underwent TME using an initial laparoscopic approach following nCRT between 2020 and 2025. Patients were stratified according to DI status. Preoperative, operative, pathological, and postoperative outcomes, including AL, 30-day postoperative complications, readmission, surgical reintervention, and stoma-related morbidity, were compared. Propensity score overlap weighting was used as the primary adjusted analysis to address confounding by indication. Results: A total of 50 patients (48.1%) underwent DI and 54 (51.9%) did not. Patients in the DI group had more distal tumors and more frequently underwent ultra-low anterior resection or intersphincteric resection. After propensity score overlap weighting, DI was not significantly associated with non-stoma-related complications within 30 days (adjusted RR, 0.935; 95% CI, 0.566–1.543; p = 0.792) or overall 30-day morbidity (adjusted RR, 1.301; 95% CI, 0.893–1.895; p = 0.158). However, DI was associated with major morbidity (adjusted RR, 4.658; 95% CI, 1.477–14.688; p = 0.004) and 30-day readmission (adjusted RR, 3.665; 95% CI, 1.397–9.621; p = 0.003). Nine patients in the DI group (18.0%) required reoperation within 30 days for stoma-related complications. Conclusions: After adjustment for baseline differences, DI was not significantly associated with overall or non-stoma-related 30-day morbidity, whereas associations with major morbidity and 30-day readmission persisted. Serious stoma-related complications may represent an important component of the early postoperative treatment burden associated with DI. These findings support careful patient selection when balancing the potential benefits of fecal diversion against stoma-related morbidity.
Background While minimally invasive surgery and traditional open surgery are generally equivalent in terms of oncological outcomes for rectal cancer, maintaining postoperative quality of life is increasingly important. Low anterior resection syndrome is a distressing complication following sphincter-preserving surgery...
Xue-Tong Jiang, Chuang Ding, Ming Zhang et al.· Frontiers in Surgery· 0 citations
BACKGROUND
Diverting loop ileostomy is commonly used to mitigate the consequences of anastomotic leakage after rectal cancer surgery. However, some patients do not undergo stoma closure, resulting in a permanent stoma that may impair quality of life. This study evaluated the closure rate, reasons for non-closure, and a...
M. Miyo, Mamoru Uemura, Yuki Ozato et al.· Journal of gastroenterology· 0 citations
To compare early and delayed diverting ileostomy closure after low anterior resection for rectal cancer, focusing on postoperative morbidity and recovery outcomes, and to assess the certainty of available evidence. PubMed/MEDLINE, Embase, Scopus, and Web of Science were searched from inception to 26th April, 2026. Five...
W. Mirza, S. Ullah, Muhammad Babar et al.· Langenbeck's archives of sur...· 0 citations
ABSTRACT Aim To evaluate the association between preoperative neoadjuvant therapy and short‐term outcomes of transanal total mesorectal excision for rectal cancer. Methods We retrospectively analyzed patients who underwent transanal total mesorectal excision at 26 Japanese institutions between 2012 and 2019. Patients w...
Takafumi Shima, Hiroki Hamamoto, T. Matsuda et al.· Annals of Gastroenterologica...· 0 citations
Robotic-assisted and open low anterior rectal resection with TME resulted in comparable QOL and anorectal function across all assessed domains, underscoring the persistent functional burden irrespective of surgical approach.
Fred L. Brocker, S. Merkel, Anne Jacobsen et al.· Langenbeck's archives of sur...· 0 citations
BACKGROUND
The interval from radiotherapy completion to surgery may affect pelvic fibrosis, operative difficulty, postoperative morbidity, and quality of rectal cancer resection. In total neoadjuvant therapy (TNT), however, this interval has different clinical content according to treatment sequence. We evaluated wheth...
José M. Aguilar-Romero, I. Vela-Sarmiento, L. Lino-Silva et al.· Journal of Surgical Oncology· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.